No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Ginwa Enterprise(Group) Inc. (600080.SH): Shareholder Xinyu Jinyu is no longer a shareholder holding more than 5% of the company's shares.
On February 18, Gelonghui reported that Ginwa Enterprise(Group) Inc. (600080.SH) announced that the company received a "Simplified Report on Equity Changes" from Shareholder Xinyu Jinyu on February 18, 2025. Xinyu Jinyu reduced its holdings by selling 133,500 shares of the company through centralized bidding on February 18, 2024 (accounting for 0.035765% of the shares held). After this change, Xinyu Jinyu's number of freely tradable shares in the company decreased from 18,797,000 to 18,663,500 shares, with the shareholding ratio decreasing from 5.04% to 4.999996%, and is no longer a significant shareholder.
Jinhua Enterprise (Group) Co., Ltd. 2024 Annual Results Forecast
Ginwa Enterprise(Group) Inc. and several senior executives have been criticized for violations of information disclosure regulations! The Chairman has just been placed under investigation | Quick Reading of Announcement.
① Due to violations of information disclosure and the use of raised funds for stock trading, Ginwa Enterprise(Group) Inc. and several senior executives including Director Xing Yajiang have been criticized. Additionally, Xing Yajiang is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws. ② According to Tianyancha, from the end of 2019 to the present, Ginwa Enterprise(Group) Inc. and personnel including Xing Yajiang have received a total of 60 penalties from the Shanghai Stock Exchange, the China Securities Regulatory Commission, and others.
Ginwa Enterprise(Group) Inc. (600080.SH): Has received a total of 0.196 billion yuan in share transfer payments from the Western Group.
On December 31, Gelonghui reported that Ginwa Enterprise(Group) Inc. (600080.SH) announced that on December 30, 2024, the company received a partial payment of 20 million yuan for the remaining Equity Transfer from the Western Group. As of the date of this announcement, the company has received a total of 195.71 million yuan in share transfer payments from the Western Group, accounting for 56.81% of the total Equity Transfer payment of 344.5263 million yuan. The Western Group has committed to repay the remaining transfer payment of 148.8163 million yuan by September 30, 2025, and has promised not to extend the payment period for any reason after the due date. If the Western Group fails to do so at that time...
Jinhua Co., Ltd.: 2023 Semi-Annual Report of Jinhua Enterprise (Group) Co., Ltd. (revised version)
Some Confidence Is Lacking In Ginwa Enterprise (Group) Inc. (SHSE:600080) As Shares Slide 29%